Navigation Links
ASPIRE Independent Review Board Announces 10 Ways to Protect Participants' Rights in Clinical Drug Trials and Optimize Results From Research
Date:6/9/2008

ASPIRE IRB Is Exhibiting at Bio International Convention in San Diego June

17-20 Currently, over 54,255 Trials with Locations in 154 Countries Are Taking

Place

SAN DIEGO, June 9 /PRNewswire/ -- ASPIRE IRB (http://www.aspire-irb.com), an Independent Review Board (IRB), is responsible for overseeing research and protecting the rights and welfare of people participating in clinical trials. ASPIRE IRB partners with drug manufacturers and research companies to get the best results from clinical drug trials and protect the rights and welfare of participants. "Making sure research is being implemented correctly is critical to the success of the study. Each study is unique. For instance people with Schizophrenia can tolerate a higher dose of particular drugs than people without the disorder. Races, because of genetics, react differently as well," explains Alycia Huston, COO of ASPIRE IRB.

The FDA and HHS regulations empower Independent Review Boards to approve or disapprove research and require modifications. They are made up of physicians, scientists, nonscientists, community members and associates affiliated with the IRB. A clinical trial CANNOT take place without an Independent Review Board.

Hundreds of thousands of people participate in clinical trials with the hope of finding relief and or to help others. Research is essential to finding cures and treatments for conditions and diseases. Being a member of a clinical trial is a big decision. It is essential for people to know their rights and understand how clinical trials work. They follow a defined protocol or study plan. It is designed to protect the health of participants and answer specific research questions.

Participating in clinical trials provides hope, can save lives and help others.

"Clinical trials for Cancer were instrumental in extending my
'/>"/>

SOURCE ASPIRE IRB
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Promise of Vicals CMV Vaccine Noted by Independent Experts
2. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
3. Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
4. Independent Studies Report on Possible Roles for Cylexs Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients
5. Longevinex(R) Found to be Superior to Green Tea Molecule in Independent Human Study
6. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
7. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
8. Independent Clinical Results Confirm Up to a 7-Centimeter Reduction in Body Circumference Using UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring System
9. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
10. Video: New Research Discovers Independent Brain Networks Control Human Walking
11. CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 Nephros, Inc. (OTC Bulletin Board: ... company that develops and sells high performance liquid purification ... offering.  In addition, the concurrent temporary reduction in exercise ... May 17, 2013. Nephros estimates that it ... rights offering.   A portion of the proceeds will be ...
(Date:5/23/2013)... May 23, 2013  MGC Diagnostics Corporation (NASDAQ: ... technology company, today scheduled a conference call to discuss ... year 2013, ended April 30, 2013. The call will ... 2013. The Company will report financial results for the ... close on Thursday, May 30, 2013. ...
(Date:5/23/2013)... Tenn. , May 23, 2013  TeamHealth ... 24-hour nurse triage and nurse advice lines, announces ... committee, comprising physician, nursing and administrative leaders, provides ... safe, quality and cost-effective services for hospital clients, ... our national healthcare system evolves, it,s imperative to ...
Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2TeamHealth Medical Call Center Forms Clinical Advisory Committee 2
... High-dose ursodeoxycholic acid detrimental for treatment of primary sclerosing cholangitis ... national team of researchers led by scientists at Mayo Clinic has ... liver disease, is not helpful for patients, according to a study ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20090105/MAYOLOGO ...
... , ZURICH, Aug. 27 /PRNewswire/ -- ... of four phase III trials have been published in the prestigious peer-reviewed ... roflumilast, a phosphodiesterase 4 (PDE4) inhibitor, improved lung function and reduced exacerbations ... COPD is an under-diagnosed progressive lung disease that may lead ...
Cached Medicine Technology:Researchers Find High-Dose Therapy for Liver Disease Not Effective 2Researchers Find High-Dose Therapy for Liver Disease Not Effective 3Researchers Find High-Dose Therapy for Liver Disease Not Effective 4Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations 2Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations 3Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations 4Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations 5Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations 6Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations 7Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations 8Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations 9
(Date:5/24/2013)... 24, 2013 Mike Stoler believes that ... successful business people in New York. That’s why ... weekly on CUNY TV. And that’s why he ... Allergy Associates, LLP (ENTA)—the largest single specialty practice in ... throat, allergy and audiology specialists and sub-specialists service communities ...
(Date:5/24/2013)... May 24, 2013 According to a May ... Social Media Leads to Spikes in Plastic Surgery ... a growing prevalence of facial plastic surgery and ... people have become keenly aware of the need to look ... as Facebook, Google and even Skype's video chat feature (Go ...
(Date:5/24/2013)... one in five parents think they have little control ... illicit drug use, a new U.S. government survey finds. ... Abuse and Mental Health Services Administration (SAMHSA), since new ... most influential forces helping to shape their child,s views ... show that parents can make an enormous difference in ...
(Date:5/24/2013)... aortic valve implantation (TAVI) is effective and safe in ... results from a multicentre Asian registry reported at EuroPCR ... a treatment option for selected patients with symptomatic severe ... North American or European centres," Paul Chiam, senior consultant ... conference. He explained that it is unknown whether the ...
(Date:5/24/2013)... Fit Yummy Mummy, a fitness program that ... trying to get rid of the belly fat in ... women who want to combine exercises with nutrition has ... Stevenson, prompting an investigative review. , “Holly's Rigsby's program ... variety of motivational strategies, nutritional plans, proper diets, and ...
Breaking Medicine News(10 mins):Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 3Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 4Health News:Facebook and Google – Is Social Media Driving Demand for Plastic Surgery? 2Health News:Parents Underestimate Influence Over Teens' Substance Abuse: Survey 2Health News:Registry confirms TAVI efficacy and safety in Asian patients 2Health News:Fit Yummy Mummy: Review Examining Holly Rigsby’s Fitness Program Released 2
... Washington, D.C., and Meet with Elected,Officials, WASHINGTON, March ... Washington, D.C., this April 1 to meet with,congressional leaders ... Disabilities Act, support for epilepsy public health,programs and more ... is one of 50 young people with epilepsy participating ...
... D.C., and Meet With Elected,Officials, WASHINGTON, March 14 ... D.C., this April 1 to meet with,congressional leaders and ... Act, support for epilepsy public health,programs and more research ... one of 50 young people with epilepsy participating in,Kids ...
... DENVER, March 14 Birner Dental Management,Services, Inc. ... dental practices,announced its regular quarterly dividend. The Company,s ... of 17 cents per share of common,stock. The ... of record,March 28, 2008., Birner Dental Management ...
... ( http://www.nhs.uk ), the,digital ,front door, to ... package on,pregnancy, aimed at helping people find ... Based on NHS accredited information, the pregnancy ... staying healthy and fit during pregnancy,including eating ...
... STE ) today announced that its Board ... $300 million in shares of STERIS common stock. ... of,February 29, 2008. This share repurchase authorization replaces ... Through March,13, 2008, the Company has repurchased approximately ...
... that processed vermiculite tainted with asbestos-like fibers that originated from ... and thickening of the membrane that lines the chest wall ... those who were exposed at or below current legal levels. ... times its original size when rapidly heated and has a ...
Cached Medicine News:Health News:Utah Youth Named National Epilepsy Spokesperson 2Health News:Tennessee Youth Named National Epilepsy Spokesperson 2Health News:STERIS Corporation Announces New $300 Million Share Repurchase Authorization 2Health News:STERIS Corporation Announces New $300 Million Share Repurchase Authorization 3Health News:Legal exposure to asbestos-like material linked to lung damage 25 years later 2Health News:Legal exposure to asbestos-like material linked to lung damage 25 years later 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: